<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03192826</url>
  </required_header>
  <id_info>
    <org_study_id>8393 / 26- 4- 2016</org_study_id>
    <nct_id>NCT03192826</nct_id>
  </id_info>
  <brief_title>Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy</brief_title>
  <official_title>Study of the Efficacy of Brinzolamide 1% Plus Brimonidine 0.2% Versus Brimonidine 0.2% in the Prevention of Intraocular Pressure Rise After Nd-YAG Laser Capsulotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Patras</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Patras</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of a Brinzolamide/Brimonidine fixed combination (FC) with Brimonidine
      0.2% in preventing intraocular pressure (IOP) elevations after neodymium:
      yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective, randomized, double masked clinical trial, patients scheduled to undergo
      Nd:YAG laser posterior capsulotomy for posterior capsule opacification are randomized in 3
      groups. The Brimonidine group receives 1 drop of Brimonidine 0.2%. The
      Brinzolamide/Brimonidine group receives 1 drop of Brinzolamide 1%/Brimonidine 0.2% fixed
      combination. The Control group receives artificial tears. All groups are administered a
      single drop instillation, approximately one hour before Nd:YAG application. Intraocular
      pressure measurements are performed before treatment (baseline) and at the 1, 3, 24 hours and
      1 week post treatment.

      Dexamethasone ophthalmic drops are prescribed q.i.d. for one week after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 20, 2016</start_date>
  <completion_date type="Actual">July 8, 2017</completion_date>
  <primary_completion_date type="Actual">July 8, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a prospective, randomized, double masked comparative study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Patients are masked to their assignment by covering the labels on the bottles of the drugs administered The investigator responsible for the measurement of the intraocular pressure is also masked to the intervention administered to each patient.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular Pressure (IOP) at 1 Hour After Nd-YAG Posterior Capsulotomy</measure>
    <time_frame>1 hour</time_frame>
    <description>Comparison of intraocular pressure at 1 hour after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular Pressure (IOP) at 3 Hours After Nd-YAG Posterior Capsulotomy</measure>
    <time_frame>3 hours</time_frame>
    <description>Comparison of intraocular pressure at 3 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular Pressure (IOP) at 24 Hourw After Nd-YAG Posterior Capsulotomy</measure>
    <time_frame>24 hours</time_frame>
    <description>Comparison of intraocular pressure at 24 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular Pressure (IOP) at 1 Week After Nd-YAG Posterior Capsulotomy</measure>
    <time_frame>1 week</time_frame>
    <description>Comparison of intraocular pressure at 1 week after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Posterior Capsule Opacification</condition>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>Brinzolamide/Brimonidine FC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brimonidine 0.2%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Artificial tears</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brinzolamide/Brimonidine FC</intervention_name>
    <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
    <arm_group_label>Brinzolamide/Brimonidine FC</arm_group_label>
    <other_name>SIMBRINZA (brinzolamide/brimonidine 1%/0.2%), Alcon Lab. Ltd</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Brimonidine 0.2%</intervention_name>
    <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
    <arm_group_label>Brimonidine 0.2%</arm_group_label>
    <other_name>ALPHAGAN (brimonidine tartrate 0.2%) Allergan Pharm. Ltd</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Artificial tears</intervention_name>
    <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
    <arm_group_label>Artificial tears</arm_group_label>
    <other_name>TEARS NATURALE EY.DRO.SOL 0.1%+0.3% Alcon Laboratories Ltd</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled to undergo laser posterior capsulotomy due to posterior capsule
             opacification (PCO) after uneventful phacoemulsification cataract extraction with
             implantation of posterior chamber intraocular lenses (IOL/PC).

        Exclusion Criteria:

          -  baseline IOP greater than 21mmHg

          -  glaucomatous eyes, already under treatment with anti glaucomatic medications

          -  intraocular surgery except for uncomplicated cataract surgery

          -  previous photorefractive surgery

          -  active ocular inflammation or infection

          -  patients under systemic administration of medications known to affect IOP

          -  patients with severe respiratory or cardiovascular disease

          -  pregnant or breast feeding women, and individuals with known hypersensitivity or
             contraindication for administration of the medications tested

          -  a measurement of IOP &gt; 30 mmHg at any time point of the study, or an increase from
             baseline &gt;20 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Constantinos Georgakopoulos, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital of Patras</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Patras</name>
      <address>
        <city>Patra</city>
        <state>Achaia</state>
        <zip>26504</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 18, 2017</study_first_submitted>
  <study_first_submitted_qc>June 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2017</study_first_posted>
  <results_first_submitted>April 16, 2019</results_first_submitted>
  <results_first_submitted_qc>June 23, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 16, 2019</results_first_posted>
  <last_update_submitted>June 23, 2019</last_update_submitted>
  <last_update_submitted_qc>June 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Patras</investigator_affiliation>
    <investigator_full_name>Constantinos D. Georgakopoulos, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD, Associate Professor of Ophthalmology, Univerisity of Patras</investigator_title>
  </responsible_party>
  <keyword>Nd-YAG capsulotomy</keyword>
  <keyword>ocular hypertension</keyword>
  <keyword>brimonidine</keyword>
  <keyword>brinzolamide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ocular Hypertension</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brimonidine Tartrate</mesh_term>
    <mesh_term>Lubricant Eye Drops</mesh_term>
    <mesh_term>Dipivefrin</mesh_term>
    <mesh_term>Brinzolamide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 24, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/26/NCT03192826/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Brinzolamide/Brimonidine FC</title>
          <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
        </group>
        <group group_id="P2">
          <title>Brimonidine 0.2%</title>
          <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
        </group>
        <group group_id="P3">
          <title>Artificial Tears</title>
          <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Brinzolamide/Brimonidine FC</title>
          <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
        </group>
        <group group_id="B2">
          <title>Brimonidine 0.2%</title>
          <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
        </group>
        <group group_id="B3">
          <title>Artificial Tears</title>
          <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="79"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.9" spread="6.3"/>
                    <measurement group_id="B2" value="65.2" spread="6.0"/>
                    <measurement group_id="B3" value="67.6" spread="3.9"/>
                    <measurement group_id="B4" value="65.5" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Greece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure (IOP) at 1 Hour After Nd-YAG Posterior Capsulotomy</title>
        <description>Comparison of intraocular pressure at 1 hour after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
        <time_frame>1 hour</time_frame>
        <population>Comparison of intraocular pressure at 1 hour after Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
        <group_list>
          <group group_id="O1">
            <title>Brinzolamide/Brimonidine FC</title>
            <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
          </group>
          <group group_id="O2">
            <title>Brimonidine 0.2%</title>
            <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
          </group>
          <group group_id="O3">
            <title>Artificial Tears</title>
            <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure (IOP) at 1 Hour After Nd-YAG Posterior Capsulotomy</title>
          <description>Comparison of intraocular pressure at 1 hour after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
          <population>Comparison of intraocular pressure at 1 hour after Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="1.5"/>
                    <measurement group_id="O2" value="15.7" spread="1.5"/>
                    <measurement group_id="O3" value="15.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" spread="2.0"/>
                    <measurement group_id="O2" value="14.7" spread="3.7"/>
                    <measurement group_id="O3" value="19.5" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The SPSS statistical package version 23.0 (Statistical Package for the Social Sciences, version 23.0, SSPS Inc. Chicago, IL, USA) was used for statistical analysis.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA was used to compare parametric values with Bonferroni post hoc test for within group comparisons.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.05</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>the reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure (IOP) at 3 Hours After Nd-YAG Posterior Capsulotomy</title>
        <description>Comparison of intraocular pressure at 3 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
        <time_frame>3 hours</time_frame>
        <population>Comparison of intraocular pressure at 3 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
        <group_list>
          <group group_id="O1">
            <title>Brinzolamide/Brimonidine FC</title>
            <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
          </group>
          <group group_id="O2">
            <title>Brimonidine 0.2%</title>
            <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
          </group>
          <group group_id="O3">
            <title>Artificial Tears</title>
            <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure (IOP) at 3 Hours After Nd-YAG Posterior Capsulotomy</title>
          <description>Comparison of intraocular pressure at 3 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
          <population>Comparison of intraocular pressure at 3 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="1.5"/>
                    <measurement group_id="O2" value="15.7" spread="1.5"/>
                    <measurement group_id="O3" value="15.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="1.5"/>
                    <measurement group_id="O2" value="14.7" spread="3.7"/>
                    <measurement group_id="O3" value="19.5" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The SPSS statistical package version 23.0 (Statistical Package for the Social Sciences, version 23.0, SSPS Inc. Chicago, IL, USA) was used for statistical analysis.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA was used to compare parametric values with Bonferroni post hoc test for within group comparisons.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.05</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>the reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure (IOP) at 24 Hourw After Nd-YAG Posterior Capsulotomy</title>
        <description>Comparison of intraocular pressure at 24 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
        <time_frame>24 hours</time_frame>
        <population>Comparison of intraocular pressure at 24 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
        <group_list>
          <group group_id="O1">
            <title>Brinzolamide/Brimonidine FC</title>
            <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
          </group>
          <group group_id="O2">
            <title>Brimonidine 0.2%</title>
            <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
          </group>
          <group group_id="O3">
            <title>Artificial Tears</title>
            <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure (IOP) at 24 Hourw After Nd-YAG Posterior Capsulotomy</title>
          <description>Comparison of intraocular pressure at 24 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
          <population>Comparison of intraocular pressure at 24 hours after Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="1.5"/>
                    <measurement group_id="O2" value="15.7" spread="1.5"/>
                    <measurement group_id="O3" value="15.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6" spread="1.1"/>
                    <measurement group_id="O2" value="15.5" spread="1.7"/>
                    <measurement group_id="O3" value="15.8" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The SPSS statistical package version 23.0 (Statistical Package for the Social Sciences, version 23.0, SSPS Inc. Chicago, IL, USA) was used for statistical analysis.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA was used to compare parametric values with Bonferroni post hoc test for within group comparisons.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.05</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>the reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure (IOP) at 1 Week After Nd-YAG Posterior Capsulotomy</title>
        <description>Comparison of intraocular pressure at 1 week after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
        <time_frame>1 week</time_frame>
        <population>Comparison of intraocular pressure at 1 weekafter Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
        <group_list>
          <group group_id="O1">
            <title>Brinzolamide/Brimonidine FC</title>
            <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
          </group>
          <group group_id="O2">
            <title>Brimonidine 0.2%</title>
            <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
          </group>
          <group group_id="O3">
            <title>Artificial Tears</title>
            <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure (IOP) at 1 Week After Nd-YAG Posterior Capsulotomy</title>
          <description>Comparison of intraocular pressure at 1 week after Nd-YAG posterior capsulotomy compared to Baseline IOP</description>
          <population>Comparison of intraocular pressure at 1 weekafter Nd-YAG posterior capsulotomy compared to Baseline IOP</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" spread="1.5"/>
                    <measurement group_id="O2" value="15.7" spread="1.5"/>
                    <measurement group_id="O3" value="15.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" spread="1.1"/>
                    <measurement group_id="O2" value="15.3" spread="1.5"/>
                    <measurement group_id="O3" value="15.6" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>The SPSS statistical package version 23.0 (Statistical Package for the Social Sciences, version 23.0, SSPS Inc. Chicago, IL, USA) was used for statistical analysis.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
            <method_desc>Repeated measures ANOVA was used to compare parametric values with Bonferroni post hoc test for within group comparisons.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.05</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>the reported p-value was calculated, and is not attempting to indicate the threshold for statistical significance</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1month</time_frame>
      <desc>The same with clinicaltrials.gov Definitions</desc>
      <group_list>
        <group group_id="E1">
          <title>Brinzolamide/Brimonidine FC</title>
          <description>1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy
Brinzolamide/Brimonidine FC: 1 drop of Brinzolamide/Brimonidine FC 1 hour before capsulotomy</description>
        </group>
        <group group_id="E2">
          <title>Brimonidine 0.2%</title>
          <description>1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy
Brimonidine 0.2%: 1 drop of Brimonidine 0.2% 1 hour before Nd-YAG capsulotomy</description>
        </group>
        <group group_id="E3">
          <title>Artificial Tears</title>
          <description>1 drop of artificial tears 1 hour before Nd-YAG capsulotomy
Artificial tears: 1 drop of artificial tears 1 hour before Nd-YAG capsulotomy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Corneal thickness was not assessed. The measurement of IOP at more time points could have provided more information regarding the effect of BBFC. We could enroll a larger group of patients in order to provide more strength in our analysis</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>OPHTHALMOLOGY PATRAS</name_or_title>
      <organization>Patras Medical School</organization>
      <phone>6975801961</phone>
      <email>cgeorg@upatras.gr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

